(+)-Cyanidan-3-ol inhibits epidermoid squamous cell carcinoma growth via inhibiting AKT/mTOR signaling through modulating CIP2A-PP2A axis

INIS

• carcinomas 100%
• growth 100%
• skin cancer 100%
• tumors 54%
• humans 45%
• skin 27%
• in vitro 18%
• in vivo 18%
• proteins 18%
• molecules 18%
• apoptosis 18%
• drugs 9%
• toxicity 9%
• diseases 9%
• mice 9%
• dmba 9%
• cell cycle 9%
• design 9%
• libraries 9%
• phenotype 9%
• induction 9%
• pcr 9%
• agar 9%
• migration 9%
• molecular biology 9%
• colony formation 9%
• vulnerability 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Squamous Cell Carcinoma 100%
• Skin Cancer 100%
• Neoplasm 27%
• Protein 18%
• Apoptosis 18%
• Tumor Growth 18%
• Western Blot 18%
• Study Design 18%
• Skin Carcinoma 18%
• Toxicity 9%
• Mouse 9%
• Dimethylbenz[a]anthracene 9%
• Cell Cycle 9%
• Tumor Model 9%
• Diseases 9%
• Drug Resistance 9%
• Agar 9%
• Natural Product 9%
• Survival 9%
• Caspase 9%
• Cancer Growth 9%
• Skin Papilloma 9%
• Matrigel 9%

Medicine and Dentistry

• mTOR Signaling 100%
• Skin Cancer Cell Line 18%
• Mammalian Target of Rapamycin Inhibitor 18%
• Dimethylbenz[a]anthracene 9%
• Skin Papilloma 9%
• Signaling Protein 9%
• Colony Formation 9%